The 59-year-old patient had a weakened immune system due to a kidney transplant and use of immunosuppressant drugs. He originally tested positive in December 2020 and continued to test positive through January 2022.
Researchers used a genetic sequencing of the virus to determine it was a variant from the beginning of the pandemic. Once identified, the man was given drugs known to work on that older variant.
The case, published in Clinical Infectious Diseases, highlighted the effectiveness of individualized therapies in patients with chronic COVID-19. The genome sequencing process offered results in 24 hours and allowed for appropriate, effective care.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
